Forbes April 25, 2018
Ellen Matloff

The DTC genetic testing revolution is here. More than 12 million people have had testing via an at-home spit kit and the numbers are sky rocketing. People have their own raw genetic data in hand, are curious and are searching for answers in their DNA. It is safe to say that the DTC train has left the station.

And yet, some of my colleagues are still tying themselves to the tracks in hopes of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Health System / Hospital, Patient / Consumer, Physician, Precision Medicine, Primary care, Provider, Technology
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce

Share This Article